Literature DB >> 26966089

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

Jean-François Emile1, Oussama Abla2, Sylvie Fraitag3, Annacarin Horne4, Julien Haroche5, Jean Donadieu6, Luis Requena-Caballero7, Michael B Jordan8, Omar Abdel-Wahab9, Carl E Allen10, Frédéric Charlotte11, Eli L Diamond12, R Maarten Egeler2, Alain Fischer13, Juana Gil Herrera14, Jan-Inge Henter15, Filip Janku16, Miriam Merad17, Jennifer Picarsic18, Carlos Rodriguez-Galindo19, Barret J Rollins20, Abdellatif Tazi21, Robert Vassallo22, Lawrence M Weiss23.   

Abstract

The histiocytoses are rare disorders characterized by the accumulation of macrophage, dendritic cell, or monocyte-derived cells in various tissues and organs of children and adults. More than 100 different subtypes have been described, with a wide range of clinical manifestations, presentations, and histologies. Since the first classification in 1987, a number of new findings regarding the cellular origins, molecular pathology, and clinical features of histiocytic disorders have been identified. We propose herein a revision of the classification of histiocytoses based on histology, phenotype, molecular alterations, and clinical and imaging characteristics. This revised classification system consists of 5 groups of diseases: (1) Langerhans-related, (2) cutaneous and mucocutaneous, and (3) malignant histiocytoses as well as (4) Rosai-Dorfman disease and (5) hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Herein, we provide guidelines and recommendations for diagnoses of these disorders.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2016        PMID: 26966089      PMCID: PMC5161007          DOI: 10.1182/blood-2016-01-690636

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  95 in total

Review 1.  Inherited defects in lymphocyte cytotoxic activity.

Authors:  Jana Pachlopnik Schmid; Jana P Schmid; Marjorie Côte; Mickaël M Ménager; Agathe Burgess; Nadine Nehme; Gaël Ménasché; Alain Fischer; Geneviève de Saint Basile
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Is macrophage activation syndrome a new entity?

Authors:  B H Athreya
Journal:  Clin Exp Rheumatol       Date:  2002 Mar-Apr       Impact factor: 4.473

Review 3.  Nosology and Pathology of Langerhans Cell Histiocytosis.

Authors:  Jennifer Picarsic; Ronald Jaffe
Journal:  Hematol Oncol Clin North Am       Date:  2015-10       Impact factor: 3.722

4.  BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis.

Authors:  Felix Sahm; David Capper; Matthias Preusser; Jochen Meyer; Albrecht Stenzinger; Felix Lasitschka; Anna-Sophie Berghoff; Antje Habel; Marion Schneider; Andreas Kulozik; Ioannis Anagnostopoulos; Leonhard Müllauer; Gunhild Mechtersheimer; Andreas von Deimling
Journal:  Blood       Date:  2012-08-02       Impact factor: 22.113

5.  Incidence and pattern of radiological central nervous system Langerhans cell histiocytosis in children: a population based study.

Authors:  Evaldas Laurencikas; Désirée Gavhed; Helen Stålemark; Ingrid van't Hooft; Daniela Prayer; Nicole Grois; Jan-Inge Henter
Journal:  Pediatr Blood Cancer       Date:  2011-02       Impact factor: 3.167

6.  Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders.

Authors:  Kudakwashe Chikwava; Ronald Jaffe
Journal:  Pediatr Dev Pathol       Date:  2004-11-08

7.  A case of interdigitating dendritic cell sarcoma/histiocytic sarcoma--a diagnostic pitfall.

Authors:  Rebecca L Johnson; Saskia Boisot; Edward D Ball; Huan-You Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

8.  Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.

Authors:  Rikhia Chakraborty; Oliver A Hampton; Xiaoyun Shen; Stephen J Simko; Albert Shih; Harshal Abhyankar; Karen Phaik Har Lim; Kyle R Covington; Lisa Trevino; Ninad Dewal; Donna M Muzny; Harshavardhan Doddapaneni; Jianhong Hu; Linghua Wang; Philip J Lupo; M John Hicks; Diana L Bonilla; Karen C Dwyer; Marie-Luise Berres; Poulikos I Poulikakos; Miriam Merad; Kenneth L McClain; David A Wheeler; Carl E Allen; D Williams Parsons
Journal:  Blood       Date:  2014-09-08       Impact factor: 22.113

9.  An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.

Authors:  Scott W Canna; Adriana A de Jesus; Sushanth Gouni; Stephen R Brooks; Bernadette Marrero; Yin Liu; Michael A DiMattia; Kristien J M Zaal; Gina A Montealegre Sanchez; Hanna Kim; Dawn Chapelle; Nicole Plass; Yan Huang; Alejandro V Villarino; Angelique Biancotto; Thomas A Fleisher; Joseph A Duncan; John J O'Shea; Susanne Benseler; Alexei Grom; Zuoming Deng; Ronald M Laxer; Raphaela Goldbach-Mansky
Journal:  Nat Genet       Date:  2014-09-14       Impact factor: 38.330

10.  Genetic predisposition to hemophagocytic lymphohistiocytosis: Report on 500 patients from the Italian registry.

Authors:  Valentina Cetica; Elena Sieni; Daniela Pende; Cesare Danesino; Carmen De Fusco; Franco Locatelli; Concetta Micalizzi; Maria Caterina Putti; Andrea Biondi; Franca Fagioli; Lorenzo Moretta; Gillian M Griffiths; Lucio Luzzatto; Maurizio Aricò
Journal:  J Allergy Clin Immunol       Date:  2015-09-02       Impact factor: 10.793

View more
  239 in total

1.  Assessment of BRAFV600E mutation in pulmonary Langerhans cell histiocytosis in tissue biopsies and bronchoalveolar lavages by droplet digital polymerase chain reaction.

Authors:  Clémence Pierry; Charline Caumont; Elodie Blanchard; Camille Brochet; Gael Dournes; Audrey Gros; Thomas Bandres; Séverine Verdon; Marion Marty; Hugues Bégueret; Jean-Philippe Merlio
Journal:  Virchows Arch       Date:  2017-07-15       Impact factor: 4.064

2.  Targetable driver mutations in multicentric reticulohistiocytosis.

Authors:  Norihiro Murakami; Tomohisa Sakai; Eisuke Arai; Hideki Muramatsu; Daisuke Ichikawa; Shuji Asai; Yoshie Shimoyama; Naoki Ishiguro; Yoshiyuki Takahashi; Yusuke Okuno; Yoshihiro Nishida
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

3.  BRAF-V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor.

Authors:  Rosemarie Mastropolo; Allison Close; Steven W Allen; Kenneth L McClain; Scott Maurer; Jennifer Picarsic
Journal:  Blood Adv       Date:  2019-06-25

Review 4.  [Histiocytosis in the dermatological context of the new classification].

Authors:  C Lang; J-T Maul; L Krähenbühl; F Dimitriou; R Dummer
Journal:  Hautarzt       Date:  2019-09       Impact factor: 0.751

5.  Erdheim-Chester disease associated with chronic myelomonocytic leukemia harboring the same clonal mutation.

Authors:  Pauline Bonnet; François Chasset; Philippe Moguelet; Noémie Abisror; Raphaël Itzykson; Jean-David Bouaziz; Pierre Hirsch; Annick Barbaud; Julien Haroche; Arsène Mekinian; Zofia Hélias-Rodzewicz; Emmanuelle Clappier; Pierre Fenaux; Olivier Fain; Abdellatif Tazi; Jean-François Emile
Journal:  Haematologica       Date:  2019-06-20       Impact factor: 9.941

6.  ALK-positive histiocytosis with KIF5B-ALK fusion in an adult female.

Authors:  Gaurav K Gupta; Liqiang Xi; Svetlana D Pack; Jennifer B Jones; Stefania Pittaluga; Mark Raffeld; Elaine S Jaffe
Journal:  Haematologica       Date:  2019-08-01       Impact factor: 9.941

7.  Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.

Authors:  Paul Milne; Venetia Bigley; Chris M Bacon; Antoine Néel; Naomi McGovern; Simon Bomken; Muzlifah Haniffa; Eli L Diamond; Benjamin H Durham; Johannes Visser; David Hunt; Harsha Gunawardena; Mac Macheta; Kenneth L McClain; Carl Allen; Omar Abdel-Wahab; Matthew Collin
Journal:  Blood       Date:  2017-05-16       Impact factor: 22.113

Review 8.  The genetics of macrophage activation syndrome.

Authors:  Grant S Schulert; Randy Q Cron
Journal:  Genes Immun       Date:  2020-04-15       Impact factor: 2.676

9.  Abdominal involvement in Erdheim-Chester disease (ECD): MRI and CT imaging findings and their association with BRAFV600E mutation.

Authors:  Moozhan Nikpanah; Lauren Kim; S Mojdeh Mirmomen; Rolf Symons; Ioannis Papageorgiou; William A Gahl; Kevin O'Brien; Juvianee I Estrada-Veras; Ashkan A Malayeri
Journal:  Eur Radiol       Date:  2018-03-19       Impact factor: 5.315

10.  Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells.

Authors:  Benjamin H Durham; Damien Roos-Weil; Claude Baillou; Fleur Cohen-Aubart; Akihide Yoshimi; Makoto Miyara; Matthias Papo; Zofia Hélias-Rodzewicz; Nathalie Terrones; Neval Ozkaya; Ahmet Dogan; Raajit Rampal; Fanny Urbain; Lucie Le Fèvre; Eli L Diamond; Christopher Y Park; Thomas Papo; Frédéric Charlotte; Guy Gorochov; Valérie Taly; Olivier A Bernard; Zahir Amoura; Omar Abdel-Wahab; François M Lemoine; Julien Haroche; Jean-François Emile
Journal:  Blood       Date:  2017-05-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.